Evidence map›Paper›PMID 41904721›Full record

ReviewCellular and molecular life sciences : CMLS2026

From molecular mechanisms of glycosphingolipid function to bio-therapeutic applications.

Abhijit Saha, Ludger Johannes

Abstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Abhijit SahaCenter for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Biscay Technology Park, Building 801A, 48160, Derio, Spain. asaha@cicbiogune.es.ORCID http://orcid.org/0000-0001-8241-7253
Ludger JohannesChemical Biology of Cancer Unit, Institut Curie, Université PSL, U1339 INSERM, UMR3666 CNRS, Paris, France. ludger.johannes@curie.fr.ORCID http://orcid.org/0000-0002-2168-0004

Funding

Agence Nationale de la Recherche ANR-22-CE11-0030-03Agence Nationale de la Recherche ANR-25-CE11-0988-01Agence Nationale de la Recherche PEPR ANR-22-PEBI-0007Fondation ARC pour la Recherche sur le Cancer ARCPGA2024110009062_9628Institut National Du Cancer 2019-1-PLBIO-05-1Labex CelTisPhyBio 11-LABX-0038Ligue Contre le Cancer AAPARN 2021.LCC/ChPUniversité de Recherche Paris Sciences et Lettres ANR-10-IDEX-0001-02 PSL
6 · The paper itself

Abstract

Glycosphingolipids (GSLs) are regulators of membrane organization and trafficking. According to the glycolipid-lectin (GL-Lect) driven endocytosis model, GSLs are part of a mechanism in which they are used by oligomeric lectins from pathogens or cells to build tubular endocytic pits from which clathrin-independent endocytic carriers detach by friction-driven scission. This review revisits the unique architectural logic of GSLs and explores how this underpins mechanisms for endocytic trafficking and signaling. We examine notably how GSLs orchestrate retrograde trafficking from the plasma membrane to the Golgi apparatus and subsequent polarized secretion in specialized contexts such as migrating cells, epithelial tissues, and immune synapses. Despite their importance, GSL functions have remained difficult to explore, because of the scarcity of minimally perturbing, chemically defined tools. We survey recent development in GSL probe design and discuss principles for next-generation tools that retain native function while enabling mechanistic dissection. Finally, we discuss how these advances are reshaping therapeutic strategies, with implications for vaccine delivery, cancer targeting, and lysosomal storage disorders. Collectively, this review reframes GSLs as substrates of membrane organization, with vast untapped potential in both cellular membrane biology and translational medicine.

Indexed as

GlycosphingolipidsAnimalsCell MembraneEndocytosisGolgi ApparatusHumansSignal TransductionGlycosphingolipidsBio-therapeutic applicationsClathrin-independent endocytosisEndocytic traffickingGlycolipid-lectin (GL-Lect) driven endocytosisGlycosphingolipidsRetrograde transport

Identifiers

PMID41904721
PMCPMC13048881

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.